• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Japan Microbiome Sequencing Services Market

    ID: MRFR/HC/52147-HCR
    200 Pages
    Garvit Vyas
    September 2025

    Japan Microbiome Sequencing Services Market Research Report: By Technology (Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, Others) andBy Application (Gastrointestinal Diseases, Infectious Diseases, CNS Diseases, Oncology, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Microbiome Sequencing Services Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    Japan Microbiome Sequencing Services Market Summary

    The Japan Microbiome Sequencing Services market is projected to grow significantly from 78 USD million in 2024 to 386 USD million by 2035.

    Key Market Trends & Highlights

    Japan Microbiome Sequencing Services Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 15.65 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 386 USD million, indicating robust growth potential.
    • In 2024, the market is valued at 78 USD million, reflecting the current demand for microbiome sequencing services in Japan.
    • Growing adoption of microbiome sequencing technologies due to increasing awareness of personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 78 (USD Million)
    2035 Market Size 386 (USD Million)
    CAGR (2025-2035) 15.65%

    Major Players

    GeneWiz, Zymo Research, Fulgent Genetics, Macrogen, BioRad Laboratories, Roche, Qiagen, Eurofins Scientific, Dunlee, Thermo Fisher Scientific, Illumina, Novogene, Agilent Technologies, Microbial Genomics, BGI Genomics

    Japan Microbiome Sequencing Services Market Trends

    Several substantial trends are currently being observed in the Japan Microbiome Sequencing Services Market, which is being driven by technological advancements and an increasing emphasis on personalized medicine. The Japanese government has been actively promoting research initiatives to improve comprehension of the human microbiome, thereby nurturing collaborations between academia and industry. 

    This has led to an increased demand for microbiome sequencing services, which are intended to address a variety of health concerns, such as disease prevention and gastrointestinal health. Moreover, the expansion of this market is being facilitated by the emergence of biotechnology companies in Japan, which are utilizing innovative sequencing techniques to conduct more comprehensive and precise microbiome-based analyses. Integration of sequencing data with artificial intelligence and big data analytics to enhance health outcomes is one of the opportunities in the Japan Microbiome Sequencing Services Market.

    The potential to captivate new segments of consumers who are seeking customized healthcare solutions based on their microbiome profiles is present as more organizations in Japan invest in data-driven healthcare solutions. Furthermore, healthcare providers are being compelled to incorporate microbiome analysis into their standard practices as a result of the growing recognition of the microbiome's relevance to a variety of diseases, including obesity, diabetes, and mental health disorders.

    Japan Microbiome Sequencing Services Market Drivers

    Market Segment Insights

    Microbiome Sequencing Services Market Technology Insights

    The Japan Microbiome Sequencing Services Market within the Technology segment plays a crucial role in advancing genomic research and healthcare solutions. This segment includes various methods such as Sequencing by Litigation (SBL), Sequencing by Synthesis (SBS), Short Gun Sequencing, Targeted Gene Sequencing, RNA Sequencing, and others, each contributing uniquely to the understanding of microbiomes. 

    For instance, Short Gun Sequencing is recognized for its comprehensive approach, allowing the analysis of entire genomes, which is vital for accurate microbiome characterization.In contrast, Sequencing by Synthesis (SBS) holds a significant position due to its ability to provide high-throughput sequencing data, making it indispensable for large-scale genomic studies. 

    Targeted Gene Sequencing focuses on specific areas of interest, thereby expediting discovery in clinical applications by honing in on genes that influence health outcomes. Additionally, RNA Sequencing has gained traction as it offers valuable insights into gene expression patterns, essential for understanding microbial interactions and functions in various environments.This diversity in technological approaches fosters innovation and enhances the overall capabilities of microbiome research in Japan. The continuous evolution of these techniques is driven by advancements in computational tools and bioinformatics, enabling researchers to process and analyze vast amounts of data efficiently.

    The Japanese government actively supports microbiome research through funding initiatives and collaboration with academic institutions, positioning the country to lead in this burgeoning field. Overall, the significance and interplay of these technological methods highlight the critical opportunities and challenges faced within the Japan Microbiome Sequencing Services Market.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Microbiome Sequencing Services Market Application Insights

    The Application segment of the Japan Microbiome Sequencing Services Market plays a crucial role in addressing a variety of health issues and enhancing patient outcomes. With the increasing prevalence of gastrointestinal diseases, there is growing interest in understanding how microbiome composition influences these conditions. Infectious diseases also benefit significantly from microbiome research, as insights gained can lead to better diagnostic and therapeutic approaches.

    CNS diseases represent another vital area as emerging studies link gut microbiota to neurological health, suggesting new avenues for treatment.Oncology, too, is gaining traction, with research exploring the interplay between the microbiome and cancer therapies, potentially paving the way for personalized medicine. The category of 'Others' encompasses various applications that further underline the market's versatility and the increasing recognition of the microbiome's role in overall health. The rising investment in Research and Development for these applications contributes to the ever-expanding landscape of the Japan Microbiome Sequencing Services Market, indicating significant opportunities for growth and innovation within the industry.

    Get more detailed insights about Japan Microbiome Sequencing Services Market Research Report - Forecast to 2035

    Regional Insights

    Key Players and Competitive Insights

    The Japan Microbiome Sequencing Services Market is characterized by a rapidly evolving landscape as advancements in sequencing technology and a growing understanding of the microbiome's role in health and disease spur increased investment and interest in this field. Within this market, a variety of players range from established biotechnology firms to emerging startups, each seeking to capitalize on the immense potential of microbiome research. 

    Competitive dynamics are influenced by factors such as technological innovation, research partnerships, and the integration of bioinformatics services. As companies navigate this landscape, they are focused on differentiating their offerings through specialization in service delivery, precision, and comprehensive data analysis, making it essential for stakeholders to remain attuned to shifts in consumer demand and regulatory frameworks.GeneWiz stands out within the Japan Microbiome Sequencing Services Market due to its robust reputation for high-quality sequencing and customer service. 

    The company offers an extensive range of genomics services, including microbiome analysis, which is vital for understanding the complex interactions within microbial communities. GeneWiz has established significant market presence in Japan, leveraging its advanced technological capabilities and a team of skilled professionals to deliver precise insights. 

    This strength is complemented by their commitment to innovation and customer support, which has earned them a loyal clientele. Furthermore, GeneWiz maintains strategic collaborations with academic institutions and research organizations in Japan, further enhancing its position and allowing for the continuous evolution of its service offerings in response to market needs.Zymo Research is another key player in the Japan Microbiome Sequencing Services Market, having made considerable strides in providing cutting-edge products and services that facilitate microbiome research. 

    The company specializes in innovative solutions such as DNA and RNA extraction kits, library preparation kits, and microbial profiling solutions, which cater directly to the requirements of researchers in Japan. Zymo Research's strengths lie in its advanced product suite and a strong focus on enhancing the reproducibility and accuracy of microbial studies, which has resulted in widespread adoption in both academic and clinical settings. 

    The company's market presence is further reinforced by a series of strategic partnerships and collaborations within Japan’s research community, coupled with efforts to expand its offerings through mergers and acquisitions that align with its mission. Through its commitment to research-driven innovation, Zymo Research is well-positioned as a formidable entity in the growing field of microbiome sequencing.

    Key Companies in the Japan Microbiome Sequencing Services Market market include

    Industry Developments

    Recent developments in the Japan Microbiome Sequencing Services Market include increased investment and growth from various companies as consumer interest in personalized medicine rises. Notably, GeneWiz and Zymo Research have been at the forefront of offering innovative sequencing solutions tailored to the Japanese market demand. In a significant event, Macrogen announced a strategic partnership with Qiagen in July 2023 aimed at expanding their microbiome analysis capabilities in Japan.

    Additionally, Thermo Fisher Scientific revealed plans in August 2023 to enhance its operational footprint in Japan, reflecting the company's commitment to meet the growing demand for advanced sequencing technologies. The market has seen strong valuation growth due to these advancements, with organizations actively exploring collaborations to leverage genomic data. Over the past two to three years, the demand for microbiome research related to gut health has significantly gained traction in Japan, leading to an increased focus on R&D initiatives.

    Companies such as Illumina and Eurofins Scientific continue to play essential roles in advancing microbiome sequencing services, indicating a thriving landscape for genetic research and diagnostics in Japan.

    Market Segmentation

    Outlook

    • Gastrointestinal Diseases
    • Infectious Diseases
    • CNS Diseases
    • Oncology
    • Others

    Microbiome Sequencing Services Market Technology Outlook

    • Sequencing by Litigation (SBL)
    • Sequencing by Synthesis (SBS)
    • Short Gun Sequencing
    • Targeted Gene Sequencing
    • RNA Sequencing
    • Others

    Microbiome Sequencing Services Market Application Outlook

    • Gastrointestinal Diseases
    • Infectious Diseases
    • CNS Diseases
    • Oncology
    • Others

    Report Scope

    Report Scope:,,,,,,,,,,,,,
    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 70.97(USD Million)
    MARKET SIZE 2024 78.0(USD Million)
    MARKET SIZE 2035 386.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 15.647% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED GeneWiz, Zymo Research, Fulgent Genetics, Macrogen, BioRad Laboratories, Roche, Qiagen, Eurofins Scientific, Dunlee, Thermo Fisher Scientific, Illumina, Novogene, Agilent Technologies, Microbial Genomics, BGI Genomics
    SEGMENTS COVERED Technology, Application
    KEY MARKET OPPORTUNITIES Growing awareness of gut health, Rising demand for personalized medicine, Expansion in research funding, Technological advancements in sequencing, Increasing applications in agriculture
    KEY MARKET DYNAMICS rising healthcare expenditure, increasing research activities, growing demand for personalized medicine, advancements in sequencing technologies, supportive government initiatives
    COUNTRIES COVERED Japan

    Market Highlights

    Author
    Garvit Vyas
    Analyst

    Explore the profile of Garvit Vyas, one of our esteemed authors at Market Research Future, and access their expert research contributions in the field of market research and industry analysis

    Leave a Comment

    FAQs

    What is the expected market size of the Japan Microbiome Sequencing Services Market in 2024?

    The Japan Microbiome Sequencing Services Market is expected to be valued at 78.0 million USD in 2024.

    What is the projected market size for the Japan Microbiome Sequencing Services Market by 2035?

    By 2035, the Japan Microbiome Sequencing Services Market is anticipated to reach a value of 386.0 million USD.

    What is the expected CAGR for the Japan Microbiome Sequencing Services Market from 2025 to 2035?

    The expected CAGR for the Japan Microbiome Sequencing Services Market from 2025 to 2035 is 15.647%.

    Which technology segment is projected to dominate the market by 2035?

    By 2035, Sequencing by Synthesis (SBS) is projected to dominate the market with an estimated value of 98.0 million USD.

    What is the expected market value for Sequencing by Litigation (SBL) in 2024?

    In 2024, Sequencing by Litigation (SBL) is expected to be valued at 15.0 million USD.

    Which are the key players in the Japan Microbiome Sequencing Services Market?

    Key players in the market include GeneWiz, Zymo Research, Fulgent Genetics, Macrogen, BioRad Laboratories, and Roche.

    What will be the market size for Targeted Gene Sequencing in 2035?

    The market size for Targeted Gene Sequencing is expected to be 89.0 million USD by 2035.

    What growth opportunities exist in the Japan Microbiome Sequencing Services Market?

    Emerging trends in personalized medicine and advances in genomic technologies present significant growth opportunities.

    How might global conflicts impact the Japan Microbiome Sequencing Services Market?

    Global conflicts could impact supply chains and market dynamics, potentially affecting growth in the sector.

    What is the expected market value for RNA Sequencing in 2035?

    By 2035, RNA Sequencing is expected to reach a market value of 77.0 million USD.

    1. Primary Interviews and Information Gathering Process 3.4.2. Breakdown of Primary
    2. Respondents 3.5. Forecasting Model 3.6. Market Size Estimation 3.6.1. Bottom-Up
    3. Approach 3.6.2. Top-Down Approach 3.7. Data Triangulation 3.8. Validation 4. MARKET
    4. DYNAMICS 4.1. Overview 4.2. Drivers 4.3. Restraints 4.4. Opportunities 5. MARKET FACTOR ANALYSIS 5.1. Value chain Analysis 5.2. Porter's Five Forces Analysis 5.2.1.
    5. Bargaining Power of Suppliers 5.2.2. Bargaining Power of Buyers 5.2.3. Threat of
    6. New Entrants 5.2.4. Threat of Substitutes 5.2.5. Intensity of Rivalry 5.3. COVID-19
    7. Impact Analysis 5.3.1. Market Impact Analysis 5.3.2. Regional Impact 5.3.3. Opportunity
    8. and Threat Analysis 6. JAPAN MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY
    9. (USD MILLION) 6.1. Sequencing by Litigation (SBL) 6.2. Sequencing by Synthesis (SBS)
      1. Short Gun Sequencing 6.4. Targeted Gene Sequencing 6.5. RNA Sequencing 6.6.
    10. Others 7. JAPAN MICROBIOME SEQUENCING SERVICES MARKET, BY APPLICATION (USD MILLION)
      1. Gastrointestinal Diseases 7.2. Infectious Diseases 7.3. CNS Diseases 7.4. Oncology
      2. Others 8. COMPETITIVE LANDSCAPE 8.1. Overview 8.2. Competitive Analysis 8.3.
    11. Market share Analysis 8.4. Major Growth Strategy in the Microbiome Sequencing Services
    12. Market 8.5. Competitive Benchmarking 8.6. Leading Players in Terms of Number of
    13. Developments in the Microbiome Sequencing Services Market 8.7. Key developments
    14. and growth strategies 8.7.1. New Product Launch/Service Deployment 8.7.2. Merger
    15. & Acquisitions 8.7.3. Joint Ventures 8.8. Major Players Financial Matrix 8.8.1.
    16. Sales and Operating Income 8.8.2. Major Players R&D Expenditure. 2023 9. COMPANY
    17. PROFILES 9.1. GeneWiz 9.1.1. Financial Overview 9.1.2. Products Offered 9.1.3. Key
    18. Developments 9.1.4. SWOT Analysis 9.1.5. Key Strategies 9.2. Zymo Research 9.2.1.
    19. Financial Overview 9.2.2. Products Offered 9.2.3. Key Developments 9.2.4. SWOT Analysis
      1. Key Strategies 9.3. Fulgent Genetics 9.3.1. Financial Overview 9.3.2. Products
    20. Offered 9.3.3. Key Developments 9.3.4. SWOT Analysis 9.3.5. Key Strategies 9.4.
    21. Macrogen 9.4.1. Financial Overview 9.4.2. Products Offered 9.4.3. Key Developments
      1. SWOT Analysis 9.4.5. Key Strategies 9.5. BioRad Laboratories 9.5.1. Financial
    22. Overview 9.5.2. Products Offered 9.5.3. Key Developments 9.5.4. SWOT Analysis 9.5.5.
    23. Key Strategies 9.6. Roche 9.6.1. Financial Overview 9.6.2. Products Offered 9.6.3.
    24. Key Developments 9.6.4. SWOT Analysis 9.6.5. Key Strategies 9.7. Qiagen 9.7.1. Financial
    25. Overview 9.7.2. Products Offered 9.7.3. Key Developments 9.7.4. SWOT Analysis 9.7.5.
    26. Key Strategies 9.8. Eurofins Scientific 9.8.1. Financial Overview 9.8.2. Products
    27. Offered 9.8.3. Key Developments 9.8.4. SWOT Analysis 9.8.5. Key Strategies 9.9.
    28. Dunlee 9.9.1. Financial Overview 9.9.2. Products Offered 9.9.3. Key Developments
      1. SWOT Analysis 9.9.5. Key Strategies 9.10. Thermo Fisher Scientific 9.10.1.
    29. Financial Overview 9.10.2. Products Offered 9.10.3. Key Developments 9.10.4. SWOT
    30. Analysis 9.10.5. Key Strategies 9.11. Illumina 9.11.1. Financial Overview 9.11.2.
    31. Products Offered 9.11.3. Key Developments 9.11.4. SWOT Analysis 9.11.5. Key Strategies
      1. Novogene 9.12.1. Financial Overview 9.12.2. Products Offered 9.12.3. Key Developments
        1. SWOT Analysis 9.12.5. Key Strategies 9.13. Agilent Technologies 9.13.1.
    32. Financial Overview 9.13.2. Products Offered 9.13.3. Key Developments 9.13.4. SWOT
    33. Analysis 9.13.5. Key Strategies 9.14. Microbial Genomics 9.14.1. Financial Overview
      1. Products Offered 9.14.3. Key Developments 9.14.4. SWOT Analysis 9.14.5.
    34. Key Strategies 9.15. BGI Genomics 9.15.1. Financial Overview 9.15.2. Products Offered
      1. Key Developments 9.15.4. SWOT Analysis 9.15.5. Key Strategies 10. APPENDIX
      2. References 10.2. Related Reports LIST OF TABLESTABLE 1. LIST OF ASSUMPTIONS
    35. BY TECHNOLOGY, 2019-2035 (USD BILLIONS) TABLE 3. JAPAN MICROBIOME SEQUENCING SERVICES
    36. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) TABLE
    37. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL TABLE 5. ACQUISITION/PARTNERSHIP
    38. MARKET ANALYSIS BY TECHNOLOGY FIGURE 3. JAPAN MICROBIOME SEQUENCING SERVICES MARKET
    39. ANALYSIS BY APPLICATION FIGURE 4. KEY BUYING CRITERIA OF MICROBIOME SEQUENCING SERVICES
    40. MARKET FIGURE 5. RESEARCH PROCESS OF MRFR FIGURE 6. DRO ANALYSIS OF MICROBIOME SEQUENCING
    41. SERVICES MARKET FIGURE 7. DRIVERS IMPACT ANALYSIS: MICROBIOME SEQUENCING SERVICES
    42. MARKET FIGURE 8. RESTRAINTS IMPACT ANALYSIS: MICROBIOME SEQUENCING SERVICES MARKET
    43. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2025 (% SHARE) FIGURE 11.
    44. MICROBIOME SEQUENCING SERVICES MARKET, BY TECHNOLOGY, 2019 TO 2035 (USD Billions)
    45. Billions) FIGURE 14. BENCHMARKING OF MAJOR COMPETITORS

    Japan Microbiome Sequencing Services Market Segmentation

     

     

     

    • Microbiome Sequencing Services Market By Technology (USD Million, 2019-2035)

      • Sequencing by Litigation (SBL)
      • Sequencing by Synthesis (SBS)
      • Short Gun Sequencing
      • Targeted Gene Sequencing
      • RNA Sequencing
      • Others

     

    • Microbiome Sequencing Services Market By Application (USD Million, 2019-2035)

      • Gastrointestinal Diseases
      • Infectious Diseases
      • CNS Diseases
      • Oncology
      • Others

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials